foxo4-dri human trials results The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI alleviates RIPF. (A) Representative
Description
Extended room temperature storage (hours or days) accelerates degradation
Hugs I get the same, achy, fluey and if I sit I sleep, very suddenly and with no warning
Recovery from training or long days is noticeably faster
Civil Engineering, UCLA Last updated: July 2026 Human-researched and AI-assisted with full editorial review
